INTRAVESICAL ADMINISTRATION OF HEAT SHOCK PROTEIN 90-SURVIVIN COMPLEX INHIBITOR SUPPRESSES THE GROWTH OF NON-INVASIVE BLADDER CANCER

被引：0
|
作者：
Yano, Akihiro
Fujii, Yasuhisa
Masuda, Hitoshi
Kawakami, Satoru
Kihara, Kazunori
机构：
来源：
JOURNAL OF UROLOGY | 2010年 / 183卷 / 04期
关键词：
D O I：
10.1016/j.juro.2010.02.642
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
1143
引用
收藏
页码：E442 / E442
页数：1
相关论文
共 50 条
  • [31] THE EFFECT OF HEAT SHOCK PROTEIN 90 INHIBITORS ON HISTONE 4 LYSINE 20 METHYLATION IN BLADDER CANCER
    Coban, Nuran
    Varol, Nuray
    EXCLI JOURNAL, 2019, 18 : 195 - 203
  • [32] Heat shock protein-90, IL-6 and IL-10 in bladder cancer
    Cardillo, MR
    Sale, P
    Di Silverio, F
    ANTICANCER RESEARCH, 2000, 20 (6B) : 4579 - 4583
  • [33] Electro-motive drug administration (EMDA) of intravesical mitomycin-C in patients with high-risk non-invasive bladder cancer and failure of BCG immunotherapy
    Sockett, L. J.
    Borwell, J.
    Symes, A.
    Parker, T.
    Montgomery, B. S. I.
    Barber, N. J.
    BJU INTERNATIONAL, 2008, 101 : 50 - 50
  • [34] Hsp90 (Heat Shock Protein 90) Inhibitor Occupancy Is a Direct Determinant of Client Protein Degradation and Tumor Growth Arrest in Vivo
    Tillotson, Bonnie
    Slocum, Kelly
    Coco, John
    Whitebread, Nigel
    Thomas, Brian
    West, Kip A.
    MacDougall, John
    Ge, Jie
    Ali, Janid A.
    Palombella, Vito J.
    Normant, Emmanuel
    Adams, Julian
    Fritz, Christian C.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (51) : 39835 - 39843
  • [35] Single ablative intravesical electromotive mitomycin C administration for small non-muscle-invasive bladder cancer: a prospective study
    Decaestecker, Karel
    Lumen, Nicolaas
    Van Camp, Christel
    Oosterlinck, Willem
    ACTA CLINICA BELGICA, 2018, 73 (05) : 324 - 327
  • [36] Heat shock protein 90 inhibitor mycoepoxydiene modulates kinase signaling in cervical cancer cells and inhibits in-vivo tumor growth
    Lin, Peng
    Yi, Yuting
    Lu, Mingke
    Wang, Miaomiao
    Yang, Yang
    Lu, Yue
    Song, Siyang
    Zheng, Zhonghui
    Deng, Xianming
    Zhang, Lianru
    ANTI-CANCER DRUGS, 2015, 26 (01) : 25 - 34
  • [37] Evaluation of the Heat Shock Protein 90 Inhibitor Ganetespib as a Sensitizer to Hyperthermia-Based Cancer Treatments
    Scutigliani, Enzo M.
    Liang, Yongxin
    IJff, Marloes
    Rodermond, Hans
    Mei, Xionge
    Korver, Miriam P.
    Orie, Vaneesha S.
    Hoebe, Ron A.
    Picavet, Daisy, I
    Oei, Arlene
    Kanaar, Roland
    Krawczyk, Przemek M.
    CANCERS, 2022, 14 (21)
  • [38] Simvastatin functions as a heat shock protein 90 inhibitor against triple-negative breast cancer
    Kou, Xinhui
    Jiang, Xiaoxiao
    Liu, Huijuan
    Wang, Xuan
    Sun, Fanghui
    Han, Jiami
    Fan, Jiaxing
    Feng, Guize
    Lin, Zhaohu
    Jiang, Lan
    Yang, Yonghua
    CANCER SCIENCE, 2018, 109 (10): : 3272 - 3284
  • [39] Prognostic significance of heat shock protein 90AA1 (HSP90 alpha) in invasive breast cancer
    Alsaeed, Sami A.
    Toss, Michael
    Alsaleem, Mansour
    Aleskandarany, Mohammed
    Joseph, Chitra
    Kurozumi, Sasagu
    Ball, Graham
    Mongan, Nigel
    Green, Andrew
    Rakha, Emad
    JOURNAL OF CLINICAL PATHOLOGY, 2022, 75 (04) : 263 - 269
  • [40] Knockdown of ribonuclease inhibitor expression with siRNA in non-invasive bladder cancer cell line BIU-87 promotes growth and metastasis potentials
    Junxia Chen
    Xi Ou-Yang
    Juan Gao
    Jun Zhu
    Xiaoyan He
    Jiang Rong
    Molecular and Cellular Biochemistry, 2011, 349 : 83 - 95
12345